Dianna Maar
Bio-Rad (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research, Innovative Microfluidic and Catalytic Techniques Innovation
Most-Cited Works
- → Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer(2014)393 cited
- → Multiplexed Target Detection Using DNA-Binding Dye Chemistry in Droplet Digital PCR(2013)185 cited
- → Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non–Small Cell Lung Carcinoma(2017)38 cited
- → Mapping the deletion endpoints in individuals with 22q11.2 Deletion Syndrome by droplet digital PCR(2014)32 cited
- → Screening Newborn Blood Spots for 22q11.2 Deletion Syndrome Using Multiplex Droplet Digital PCR(2014)30 cited
- → Tumour-suppressor microRNAs regulate ovarian cancer cell physical properties and invasive behaviour(2016)27 cited
- → Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia(2022)21 cited
- → Genome concentration, characterization, and integrity analysis of recombinant adeno-associated viral vectors using droplet digital PCR(2023)15 cited
- → Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests(2023)12 cited
- → Detection of Actionable BCR-ABL1 Kinase Domain (KD) Mutations in Chronic Myeloid Leukemia (CML) Patients with Failure and Warning Response to Tyrosine Kinase Inhibitors (TKIs): Potential Impact of Next-Generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) on Clinical Decision Making(2019)5 cited